HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 23.175

Change

-0.04 (-0.16)%

Market Cap

USD 0.03B

Volume

1.44K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.59 (-1.29%)

USD 63.97B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.60 (-0.30%)

USD 13.03B
WRD:PA HSBC ETFs Public Limited Compa..

-0.13 (-0.37%)

USD 10.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.86 (-0.76%)

USD 8.86B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-1.90 (-0.41%)

USD 8.07B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.36 (-0.39%)

USD 7.15B
HHH:PA HSBC ETFs Public Limited Compa..

-0.15 (-0.28%)

USD 7.09B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.08 (-0.43%)

USD 6.59B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.81 (-0.21%)

USD 5.43B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.06 (-0.04%)

USD 5.00B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.08% 63% D 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.08% 63% D 71% C-
Trailing 12 Months  
Capital Gain 26.17% 59% D- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.17% 59% D- 70% C-
Trailing 5 Years  
Capital Gain 49.16% 62% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.16% 62% D 73% C
Average Annual (5 Year Horizon)  
Capital Gain 10.34% 64% D 64% D
Dividend Return N/A 52% F 76% C+
Total Return N/A 31% F 73% C
Risk Return Profile  
Volatility (Standard Deviation) N/A 70% C- 33% F
Risk Adjusted Return N/A 86% B+ 94% A
Market Capitalization 0.03B 10% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.